Operating Lease, Right-of-Use Asset in USD of Can-Fite BioPharma Ltd. from Q4 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Can-Fite BioPharma Ltd. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2019 to Q2 2025.
  • Can-Fite BioPharma Ltd. Operating Lease, Right-of-Use Asset for the quarter ending 30 Jun 2025 was $91K, a 46.8% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $91K +$29K +46.8% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 $111K +$59K +113% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 $62K -$25K -28.7% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 $52K -$32K -38.1% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 $87K -$24K -21.6% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 $84K -$54K -39.1% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 $111K +$34K +44.2% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 $138K +$65K +89% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 $77K +$11K +16.7% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 $73K -$9K -11% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 $66K 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 $82K 31 Dec 2019 20-F 25 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.